Today’s New Reality in Clinical Trial Readiness
We’ve talked about clinical trial readiness repeatedly in this space. Probably we all, as an industry, have a good sense of what that means — or what it used to mean. The definition has acquired a whole new dimension in recent days. For example, this post was originally planned to be about a theoretical subset of sites